TrialRheumatology (Oxford, England)2018

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Divi Cornec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.